Canopy Growth Corp Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)
Canopy Growth Corp (CGC) reported Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) of CAD 12.76 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-06-01.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue · last filed 2020-06-01
- Canopy Growth Corp equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2019 was 12.76M CAD, a 289.71% increase from fiscal 2018.
- Canopy Growth Corp equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2018 was 3.27M CAD.
| Period end | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month |
|---|---|
| 2019-12-31 | 12.76M CAD 10-K · filed 2020-06-01 |
| 2018-12-31 | 3.27M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |